Wednesday, November 27, 2019

Six Drug Companies Subpoenaed In Federal Opioid Investigation

Lisette Voytko Forbes Staff Nov 26, 2019, 04:39pm (Updated: 9:31 a.m. EST, 11/27/2019)
Topline: Brooklyn federal prosecutors have launched a criminal investigation of opioid manufacturers, first reported by the Wall Street Journal, adding yet another legal entanglement for the large corporations many have blamed for causing the country’s opioid crisis. 
·         Companies that have received subpoenas: Teva, McKesson, AmerisourceBergen, Johnson & Johnson, Amneal and Mallinckrodt (which disclosed its subpoena in a May investor filing).
·         The prosecutors are seeking to understand whether the drug companies violated the federal Controlled Substances Act for not reporting suspicious signs that opioids were being used for nonmedical purposes.
·         According to the WSJ, the probe is in its early stages and more companies are likely to be subpoenaed in the coming months.
·         Shares of all six companies were trading down leading into Tuesday afternoon’s closing bell. 
·         The first federal opioid criminal probe ended in April with Rochester Drug Cooperative Inc. agreeing to pay $20 million to the government, but two of its executives, charged with conspiracy, have yet to resolve their cases.
·         In October, McKesson, AmerisourceBergen and Teva were part of a $260 million settlement that avoided the first federal opioid trial⁠—one hour before opening arguments were scheduled to begin. 
Key background: Almost 400,000 Americans have died in the opioid epidemic over the past two decades. Millions remain addicted, costing local governments millions of dollars and creating enormous strains on law enforcement, health providers and social services. Cities began filing lawsuits against the drug companies in 2014. By 2019, the number of opioid lawsuits ballooned to more than 2,500, with nearly every U.S. state filing separate litigation as well. The total economic toll of the crisis could range from $50 billion to over $1 trillion, according to estimates.
What to watch for: Purdue Pharma (which manufactured OxyContin) is already the subject of a Justice Department probe. The company is in talks to resolve that probe while its owners, the Sackler family, offered a separate settlement of up to $12 billion in a civil opioid case and filed for bankruptcy in September. If the settlement is accepted, the Sacklers will relinquish control of Purdue.
Tangent: President Trump, who has made the fight against opioids a signature policy effort, donated his third-quarter salary (over $100,000) on Tuesday to efforts dedicated to the cause. Meanwhile, first lady Melania Trump was booed during a Tuesday speech at an opioid awareness event in Baltimore. 

https://www.forbes.com/sites/lisettevoytko/2019/11/26/six-drug-companies-subpoenaed-in-federal-opioid-investigation/?utm_source=newsletter&utm_medium=email&utm_campaign=daily-dozen&utm_campaign=daily-dozen&cdlcid=5d1670731802c8c524c78889#6bfb6aec05a7

No comments:

Post a Comment